Perceptions, Representations and Experiences of Malaria Prophylaxis in Patients Born in Endemic Areas and Living in France.
PREPAP
1 other identifier
observational
15
1 country
1
Brief Summary
The aim of this study is to analyze the perceptions, representations and expe-riences of malaria prophylaxis in patients born in endemic areas and living in France. This analysis could lead to better understanding and communication between the medical profession and patients in malaria. It would also provide patient-specific responses to their expectations, as to their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2020
CompletedFirst Posted
Study publicly available on registry
July 31, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedJune 7, 2023
June 1, 2023
1 month
July 17, 2020
June 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify perceptions, representations and experiences of malaria prophylaxis in patients coming from endemic areas living in France.
The semi directive interview
Through study completion, an average of 30 minutes
Secondary Outcomes (1)
Identification of dialogue tools allowing a better relationship of trust between doctor and patient within the framework of a prevention consultation, and better delivery of key information
Through study completion, an average of 30 minutes
Eligibility Criteria
The study will be offered to patients born in endemic areas and living in France.
You may qualify if:
- Major patients
- Born in malaria endemic areas and living in France
- Having malaria or not
- Ready for no opposition for participation in the protocol
You may not qualify if:
- Patients under guardianship or curatorship
- Patients unable to give free and informed consent
- Patients under judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre hospitalier intercommunal de Villeneuve St Georges
Villeneuve-Saint-Georges, 94190, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2020
First Posted
July 31, 2020
Study Start
September 1, 2020
Primary Completion
October 1, 2020
Study Completion
November 1, 2020
Last Updated
June 7, 2023
Record last verified: 2023-06